Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation

被引:37
作者
Wang, YQ
Krieg, AM
机构
[1] Coley Pharmaceut Grp, Wellesley, MA 02481 USA
[2] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[3] Vet Affairs Med Ctr, Iowa City, IA 52246 USA
关键词
B lymphocyte; BCR; CpG motif; immunostimulation; oligodeoxynucleotide;
D O I
10.1093/intimm/dxg020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DNA or oligodeoxynucleotides (ODN) containing unmethylated CpG motifs (CpG DNA) activate antigen-presenting cells and switch on T(h)1 immunity to antigen. B cells are synergistically activated by CpG DNA in combination with non-physiologic B cell stimulators such as polyclonal mitogen and surface Ig cross-linkers. This study shows the unexpected finding that not only CpG ODN, but also non-CpG and methylated ODN synergize with specific antigen, hen egg lysozyme (HEL), in stimulating HEL-specific B cells to proliferate, to express the early activation marker CD69 and to activate the NF-kappaB pathway. In vivo, non-CpG and methylated CpG ODN also enhanced anti-HEL antibody production in HEL-immunized mice, with a bias towards the production of T(h)1-associated isotypes. The synergy with all ODN to enhance B cell immune function was epitope-specific since neither denatured HEL nor other antigens enhanced the ODN effect on HEL-specific B cells. Furthermore, the synergy was independent of whether the ODN backbone was phosphorothioate or phosphodiester, or whether natural vertebrate genomic DNA was used. In all functional analyses, non-CpG and methylated CpG ODN showed lower activity than CpG ODN. These studies demonstrate that the presence of specific physiologic antigen might broaden the spectrum of DNA/ODN that stimulate B cells, with potential implications for the initiation and regulation of normal and pathologic immune responses.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 60 条
[1]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[2]   Characterization and modulation of immune stimulation by modified oligonucleotides [J].
Boggs, RT ;
McGraw, K ;
Condon, T ;
Flournoy, S ;
Villiet, P ;
Bennett, CF ;
Monia, BP .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (05) :461-471
[3]  
Broide D, 1998, J IMMUNOL, V161, P7054
[4]   Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P) [J].
Cafaro, A ;
Titti, F ;
Fracasso, C ;
Maggiorella, MT ;
Baroncelli, S ;
Caputo, A ;
Goletti, D ;
Borsetti, A ;
Pace, M ;
Fanales-Belasio, E ;
Ridolfi, B ;
Negri, DRM ;
Sernicola, L ;
Belli, R ;
Corrias, F ;
Macchia, I ;
Leone, P ;
Michelini, Z ;
ten Haaft, P ;
Buttò, S ;
Verani, P ;
Ensoli, B .
VACCINE, 2001, 19 (20-22) :2862-2877
[5]  
Carpentier AF, 2000, CLIN CANCER RES, V6, P2469
[6]  
Carpentier AF, 1999, CANCER RES, V59, P5429
[7]   CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism [J].
Chiaramonte, MG ;
Hesse, M ;
Cheever, AW ;
Wynn, TA .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :973-985
[8]  
Chu RS, 2000, CURR TOP MICROBIOL, V247, P199
[9]   CpG DNA as a Th1-promoting adjuvant in immunization against Trypanosoma cruzi [J].
Corral, RS ;
Petray, PB .
VACCINE, 2000, 19 (2-3) :234-242
[10]  
Cowdery J, 1996, J IMMUNOL, V156, P4570